Michael Koenen‐Bergmann

710 total citations
8 papers, 558 citations indexed

About

Michael Koenen‐Bergmann is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Physiology. According to data from OpenAlex, Michael Koenen‐Bergmann has authored 8 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Pharmaceutical Science and 2 papers in Physiology. Recurrent topics in Michael Koenen‐Bergmann's work include Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers), Asthma and respiratory diseases (2 papers) and HIV Research and Treatment (1 paper). Michael Koenen‐Bergmann is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers), Asthma and respiratory diseases (2 papers) and HIV Research and Treatment (1 paper). Michael Koenen‐Bergmann collaborates with scholars based in United States, Germany and Denmark. Michael Koenen‐Bergmann's co-authors include Robert A. Wise, Daniel Dusser, Gordon Pledger, Ronald Dahl, Antonio Anzueto, Bernd Disse, Elizabeth Joseph, Otto W. Witte, Sabine Kattenbeck and Peter M.A. Calverley and has published in prestigious journals such as New England Journal of Medicine, CHEST Journal and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael Koenen‐Bergmann

8 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Koenen‐Bergmann United States 7 354 260 98 51 36 8 558
Antonella Cotoia Italy 13 102 0.3× 35 0.1× 34 0.3× 43 0.8× 8 0.2× 43 378
Filip Mejza Poland 16 402 1.1× 486 1.9× 59 0.6× 11 0.2× 19 0.5× 31 852
Linda J Kelly United Kingdom 12 98 0.3× 125 0.5× 43 0.4× 13 0.3× 30 0.8× 30 664
Richard M. Dsida United States 14 46 0.1× 51 0.2× 40 0.4× 145 2.8× 7 0.2× 24 430
Harakh V. Dedhia United States 12 155 0.4× 51 0.2× 11 0.1× 50 1.0× 4 0.1× 30 378
Michael P. Cinquegrani United States 10 66 0.2× 34 0.1× 266 2.7× 17 0.3× 6 0.2× 19 414
Philippe Montravers France 14 177 0.5× 23 0.1× 306 3.1× 50 1.0× 6 0.2× 28 659
Satoru Beppu Japan 8 83 0.2× 19 0.1× 27 0.3× 110 2.2× 4 0.1× 21 324
T C Krejcie United States 7 78 0.2× 29 0.1× 51 0.5× 173 3.4× 2 0.1× 12 309
Angela Mahan United States 8 108 0.3× 33 0.1× 91 0.9× 9 0.2× 14 0.4× 9 398

Countries citing papers authored by Michael Koenen‐Bergmann

Since Specialization
Citations

This map shows the geographic impact of Michael Koenen‐Bergmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Koenen‐Bergmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Koenen‐Bergmann more than expected).

Fields of papers citing papers by Michael Koenen‐Bergmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Koenen‐Bergmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Koenen‐Bergmann. The network helps show where Michael Koenen‐Bergmann may publish in the future.

Co-authorship network of co-authors of Michael Koenen‐Bergmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Koenen‐Bergmann. A scholar is included among the top collaborators of Michael Koenen‐Bergmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Koenen‐Bergmann. Michael Koenen‐Bergmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wise, Robert A., Antonio Anzueto, Otto W. Witte, et al.. (2014). Tiotropium Respimat Inhaler and the Risk of Death in COPD. Survey of Anesthesiology. 58(2). 78–78. 71 indexed citations
2.
Wise, Robert A., Antonio Anzueto, Otto W. Witte, et al.. (2013). Tiotropium Respimat Inhaler and the Risk of Death in COPD. New England Journal of Medicine. 369(16). 1491–1501. 256 indexed citations
3.
Wise, Robert A., Antonio Anzueto, Peter M.A. Calverley, et al.. (2013). The Tiotropium Safety and Performance in Respimat® Trial (TIOSPIR®), a large scale, randomized, controlled, parallel-group trial-design and rationale. Respiratory Research. 14(1). 40–40. 42 indexed citations
4.
Anzueto, Antonio, Robert A. Wise, Gordon Pledger, et al.. (2013). The Tiotropium Safety and Performance in Respimat (TIOSPIR) trial: Bronchodilator efficacy in a spirometry substudy. CHEST Journal. 144(4). 1027A–1027A. 2 indexed citations
5.
Härtter, Sebastian, Michael Koenen‐Bergmann, Ashish Sharma, et al.. (2012). Decrease in the oral bioavailability of dabigatran etexilate after co‐medication with rifampicin. British Journal of Clinical Pharmacology. 74(3). 490–500. 98 indexed citations
6.
Haertter, Sebastian, et al.. (2009). Population In Vitro-In Vivo Correlation Model for Pramipexole Slow-Release Oral Formulations. Pharmaceutical Research. 27(2). 340–349. 18 indexed citations
7.
Huang, Fenglei, Michael Koenen‐Bergmann, Thomas R. MacGregor, et al.. (2008). Pharmacokinetic and Safety Evaluation of BILR 355, a Second-Generation Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 52(12). 4300–4307. 15 indexed citations
8.
Röpcke, Heiko, Benno Rehberg, Michael Koenen‐Bergmann, et al.. (2001). Surgical Stimulation Shifts EEG Concentration–Response Relationship of Desflurane. Anesthesiology. 94(3). 390–399. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonella Cotoia Breakdown of academic impact, for papers by Filip Mejza Breakdown of academic impact, for papers by Linda J Kelly Breakdown of academic impact, for papers by Richard M. Dsida Breakdown of academic impact, for papers by Harakh V. Dedhia Breakdown of academic impact, for papers by Michael P. Cinquegrani Breakdown of academic impact, for papers by Philippe Montravers Breakdown of academic impact, for papers by Satoru Beppu Breakdown of academic impact, for papers by T C Krejcie Breakdown of academic impact, for papers by Angela Mahan
Rankless by CCL
2026